John Gordon
Profile
John Gordon worked as an Associate Director-CNS Clinical Development at Forest Laboratories, Inc., as a Director-Clinical Operations at Cleveland BioLabs, Inc., and as a Director-Clinical Research at Cancer Treatment Centers of America, Inc. He obtained an undergraduate degree from Rockhurst University and a doctorate degree from the University of Kansas.
Former positions of John Gordon
| Companies | Position | End |
|---|---|---|
| FOREST LABORATORIES, INC. | Corporate Officer/Principal | - |
Cancer Treatment Centers of America, Inc.
 Cancer Treatment Centers of America, Inc. Hospital/Nursing ManagementHealth Services Cancer Treatment Centers of America, Inc. operates cancer treatment hospitals. It offers surgical oncology, chemotherapy, radiation therapy, stem cell transplantation, and photodynamic therapy treatments. The firm provides treatments for bladder, colon, kidney, lung, ovarian, pancreatic, and skin cancer. The company was founded by Richard J. Stephenson in 1988 and is headquartered in Schaumburg, IL. | Chief Tech/Sci/R&D Officer | - |
| STATERA BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | - |
Training of John Gordon
| Rockhurst University | Undergraduate Degree |
| University of Kansas | Doctorate Degree |
Experiences
Positions held
Linked companies
| Private companies | 3 |
|---|---|
Cleveland BioLabs, Inc.
 Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. | Health Technology |
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
Cancer Treatment Centers of America, Inc.
Cancer Treatment Centers of America, Inc. Hospital/Nursing ManagementHealth Services Cancer Treatment Centers of America, Inc. operates cancer treatment hospitals. It offers surgical oncology, chemotherapy, radiation therapy, stem cell transplantation, and photodynamic therapy treatments. The firm provides treatments for bladder, colon, kidney, lung, ovarian, pancreatic, and skin cancer. The company was founded by Richard J. Stephenson in 1988 and is headquartered in Schaumburg, IL. | Health Services |
- Stock Market
- Insiders
- John Gordon
